文献速递肝病

严重感染对慢性肝病患者死亡率的影响:一项全国性人群队列研究

Impact of Serious Infection on Mortality of Patients With Chronic Liver Disease: A Nationwide Population-based Cohort Study.
PubMed 文献 · Clin Gastroenterol Hepatol · 2025-07-10

该研究纳入2009至2021年韩国国民健康保险服务中1,699,159例慢性肝病患者,按严重感染次数分层分析全因死亡率。结果显示死亡率随感染次数和肝病严重程度增加而升高,失代偿期肝硬化发生严重感染的风险是无肝硬化患者的3倍以上。

要点

  • 严重感染次数越多,慢性肝病患者全因死亡率越高。
  • 失代偿期肝硬化患者发生严重感染的风险是无肝硬化患者的3倍以上。
  • 肺炎是慢性肝病患者最常见的严重感染类型。

核心结论

  • 慢性肝病患者死亡率随严重感染次数增加和肝病严重程度加重(从无肝硬化、代偿期肝硬化到失代偿期肝硬化)呈升高趋势。

研究设计与样本

  • 基于韩国国民健康保险服务2009至2021年数据的全国性人群队列研究,纳入1,699,159例慢性肝病患者。

主要发现

  • 随访期间共发生336,602次严重感染,肺炎最常见,其次为严重胃肠道感染、肾盂肾炎和菌血症。
  • 0次、1次和≥2次严重感染患者的死亡率分别为3.94、41.58和114.03/1000人年。
  • 与无感染相比,1次感染的全因死亡调整风险比为6.04(95%CI 5.96-6.13),≥2次感染为13.40(95%CI 13.20-13.60)。
  • 与无肝硬化相比,代偿期肝硬化发生严重感染的调整风险比为1.99(95%CI 1.97-2.02),失代偿期肝硬化为3.31(95%CI 3.26-3.37)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: This study aimed to investigate the impact of serious infection on mortality of patients with chronic liver disease (CLD). METHODS: This study was conducted on 1,699,159 patients with CLD from the Korean National Health Insurance Service between 2009 and 2021. Serious infection was defined as acute meningitis, acute osteomyelitis, bacteremia, pneumonia, pyelonephritis, serious gastrointestinal infection, skin and soft tissue infections, spontaneous bacterial peritonitis, or COVID-19 infection. The primary outcome was all-cause mortality stratified by serious infection episodes (0, 1, and ≥2). RESULTS: The mean age of patients was 57.4 years, with 55.6% being men. Among them, the proportion of CLD without cirrhosis, compensated cirrhosis, and decompensated cirrhosis was 77.5% (n = 1,317,468), 17.5% (n = 296,617), and 5.0% (n = 85,074), respectively. During follow-up, there were 336,602 episodes of serious infections, with pneumonia being the most common, followed by serious gastrointestinal infection, pyelonephritis, and bacteremia. Mortality rates were 3.94, 41.58, and 114.03 per 1000 person-years in patients with 0, 1, and ≥2 serious infections, respectively. Multivariable analysis indicated that adjusted hazard ratios (aHRs) for mortality were 6.04 (95% confidence interval [CI], 5.96-6.13) for 1 infection and 13.40 (95% CI, 13.20-13.60) for ≥2 infections, compared with no infections. Compared with CLD without cirrhosis, the development of serious infection was higher in compensated cirrhosis (aHR, 1.99; 95% CI, 1.97-2.02) and decompensated cirrhosis (aHR, 3.31; 95% CI, 3.26-3.37). CONCLUSIONS: Patients with CLD exhibited a trend of increased mortality dependent on the number of serious infections and the degree of disease severity of CLD, ranging from CLD without cirrhosis, compensated cirrhosis, and decompensated cirrhosis. Decompensated cirrhosis has more than a 3-fold risk of infection than CLD without cirrhosis.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Jeong JY, Cho JY, Kang D, et al. Impact of Serious Infection on Mortality of Patients With Chronic Liver Disease: A Nationwide Population-based Cohort Study. Clin Gastroenterol Hepatol. 2025. PMID: 40651781. doi:10.1016/j.cgh.2025.06.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。